Brad Webb

Investor

Venture Partner at Claremont Creek Ventures

About

Brad Webb has three decades of experience as an entrepreneur and investor in the biomedical and biotechnology industries, and at CCV concentrates on how genomics and biomarker data analytics can advance diagnostics and drug development. Before CCV he worked in the medical device sector focused on eye surgery, founded Vision Biology (acquired by Alcon Laboratories, now part of Novartis), and served as an R&D scientist at 3M Company in its ophthalmology products division. He holds a PhD in Biochemistry and Molecular Biology from UC Santa Barbara, along with Master's and Bachelor's degrees in Chemistry.

Invests in

BiotechDigital HealthHealthtechMedical Devices

Deals · 1

GenalyteLed round

via Claremont Creek Ventures

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Claremont Creek Ventures

John Steuart

Venture Partner at Claremont Creek Ventures

Nat Goldhaber

Managing Director at Claremont Creek Ventures

Randy Hawks

Managing Director at Claremont Creek Ventures